Cardiovascular adverse events with cdk4/6 inhibitors:a meta-analysis of randomized controlled trials
Event: ESC Cardio-Oncology 2025
Topic: Diagnosis and Management of Cardiovascular Disease in Patients with Cancer
Session: Risk stratification for cancer therapy-related cardiovascular disease
